ELDN — Eledon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Eledon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8.79	114	84.8	56.4	51.1
Net Total Receivables	0.245	0.11	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.97	116	88.3	59.5	56.1
Net Property, Plant And Equipment	0.321	0.138	0.768	0.739	0.365
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	10.9	197	171	92.8	89.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.32	2.48	4.4	6.47	3.9
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.47	6.59	6.55	8.61	5.65
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	9.46	191	164	84.2	83.4
Total Liabilities & Shareholders' Equity	10.9	197	171	92.8	89.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding